A

Arrowhead Pharmaceuticals
D

ARWR

19.560
USD
0.54
(2.84%)
مغلق
حجم التداول
21,124
الربح لكل سهم
-4
العائد الربحي
-
P/E
-4
حجم السوق
2,433,937,686
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -2.740
    (-1.10%)
    246.360 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    MRNA
    MRNA
    0.310
    (0.92%)
    34.050 USD
    N
    NTLA
    0.09000
    (0.96%)
    9.50000 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    S
    SLDB
    0.00500
    (0.15%)
    3.26000 USD
    V
    VYGR
    0.01000
    (0.20%)
    5.06000 USD
    المزيد
الأخبار
المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.